Related Experiment Video
Updated: Jul 16, 2026
13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
[Pharmacogenetics II. Research molecular methods, bioinformatics and ethical concerns]
1Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, España. estebandauden@medynet.com
Actas Dermo-Sifiliograficas
|March 22, 2007
Summary
Pharmacogenetics optimizes drug therapy by analyzing genetic variations for personalized medicine. This review covers molecular methods like DNA microarrays for gene expression and genotyping, including single nucleotide polymorphisms (SNPs).
Area of Science:
- Pharmacogenetics
- Molecular Biology
- Genomics
Context:
- Pharmacogenetics studies individual drug responses based on genotype.
- Personalized therapy aims for safer and more efficient patient treatment.
- The review explores molecular techniques and their applications in pharmacogenetics.
Purpose:
- To review the molecular methods used in pharmacogenetics research.
- To highlight the utility of microarray technology for gene expression and genotyping.
- To discuss the interplay between pharmacogenetics, bioinformatics, and ethical considerations.
Summary:
- Pharmacogenetics analyzes genetic variations to tailor drug treatments for individuals.
- Microarray technology, including DNA chips, is crucial for detecting RNA sequences (gene expression) and DNA sequences (genotype), particularly single nucleotide polymorphisms (SNPs).
- The review examines the integration of pharmacogenetics with bioinformatics and addresses associated ethical concerns.
Impact:
- Enables the development of personalized medicine strategies.
- Advances the understanding and application of molecular diagnostic tools.
- Provides insights into the ethical landscape of genetic information in healthcare.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...